Skip to main content

Recent Patents on CNS Drug Discovery publishes review articles on recent patents in the field of CNS drug discovery e.g. novel bioactive compounds, analogs & targets. A selection of important and recent patents on CNS drug discovery is also included in the journal. The journal is essential reading for all researchers involved in CNS drug design and discovery.

Publisher: Bentham Science Publishers

Volume 4, Number 1, January 2009

Articles

Advances in Oncolytic Virus Therapy for Glioma
pp. 1-13(13)
Authors: Haseley, Amy; Alvarez-Breckenridge, Christopher; Chaudhury, Abhik R.; Kaur, Balveen

Favourites:
ADD

Recent Advancements in Anti-Migraine Drug Research: Focus on Attempts to Decrease Neuronal Hyperexcitability
pp. 14-36(23)
Authors: Bolcskei, Hedvig; Farkas, Bence; Kocsis, Pal; Tarnawa, Istvan

Favourites:
ADD

Humanin; A Defender Against Alzheimer's Disease?
pp. 37-42(6)
Author: Matsuoka, Masaaki

Favourites:
ADD

Contemporary Anticholinesterase Pharmaceuticals of Natural Origin and Their Synthetic Analogues for the Treatment of Alzheimer's Disease
pp. 43-51(9)
Authors: Orhan, Gurdal; Orhan, Ilkay; Subutay-Oztekin, Nese; Ak, Fikri; Sener, Bilge

Favourites:
ADD

Multitasking of Neuropeptide Y through the Lens of Motifs
pp. 52-60(9)
Author: Myslobodsky, Michael

Favourites:
ADD

The Role of Melatonin in the Immuno-Neuro-Psychology of Mental Disorders
pp. 61-69(9)
Authors: Maldonado, Maria D.; Perez-San-Gregorio, Maria A.; Reiter, Russel J.

Favourites:
ADD

Individual Triptan Selection in Migraine Attack Therapy
pp. 70-81(12)
Authors: Belvis, Robert; Pagonabarraga, Javier; Kulisevsky, Jaime

Favourites:
ADD

Patent Selections
pp. 82-85(4)
Author: Publishers

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more